rs169068

Variant names:

• chr16-1079872-C-A
• rs169068
• NM_001172560.3:c.1004C>A

Your query was ambiguous. Multiple possible variants found:

• chr16-1079872-C-A
• chr16-1079872-C-G
• chr16-1079872-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2 BP4_Strong

The NM_001172560.3(SSTR5):​c.1004C>A​(p.Pro335Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P335L) has been classified as Benign.

• Frequency: Genomes: not found (cov: 35)
• Consequence: SSTR5 NM_001172560.3 missense
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.117
• Publications: 43 publications found

Genes affected

SSTR5 (HGNC:11334): (somatostatin receptor 5) Somatostatin and its related peptide cortistatin exert multiple biological actions on normal and tumoral tissue targets by interacting with somatostatin receptors (SSTRs). The protein encoded by this gene is one of the SSTRs, which is a multi-pass membrane protein and belongs to the G-protein coupled receptor 1 family. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase, and different regions of this receptor molecule are required for the activation of different signaling pathways. A mutation in this gene results in somatostatin analog resistance. Alternatively spliced transcript variants have been identified in this gene.[provided by RefSeq, Feb 2010]

ACMG classification

Our verdict: Likely_benign. The variant received -2 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (MetaRNN=0.06477359).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001172560.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	SSTR5	NM_001172560.3	MANE Select	c.1004C>A	p.Pro335Gln	missense	Exon 2 of 2	NP_001166031.1
	SSTR5	NM_001053.4		c.1004C>A	p.Pro335Gln	missense	Exon 1 of 1	NP_001044.1

Ensembl Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	SSTR5	ENST00000689027.1	MANE Select	c.1004C>A	p.Pro335Gln	missense	Exon 2 of 2	ENSP00000508487.1
	SSTR5	ENST00000293897.7	TSL:6	c.1004C>A	p.Pro335Gln	missense	Exon 1 of 1	ENSP00000293897.4
	SSTR5	ENST00000711615.1		c.1004C>A	p.Pro335Gln	missense	Exon 2 of 2	ENSP00000518810.1

Frequencies

GnomAD3 genomes Cov.: 35

GnomAD4 exome Cov.: 77

GnomAD4 genome Cov.: 35

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.081
BayesDel_addAF	Benign	-0.13	T
BayesDel_noAF	Benign	-0.42
CADD	Benign	13
DANN	Benign	0.75
DEOGEN2	Benign	0.043	T
Eigen	Benign	-0.71
Eigen_PC	Benign	-0.73
FATHMM_MKL	Benign	0.091	N
LIST_S2	Benign	0.49	T
M_CAP	Uncertain	0.090	D
MetaRNN	Benign	0.065	T
MetaSVM	Benign	-0.79	T
MutationAssessor	Benign	1.3	L
PhyloP100		0.12
PrimateAI	Benign	0.32	T
PROVEAN	Benign	-0.48	N
REVEL	Benign	0.078
Sift	Benign	0.21	T
Sift4G	Benign	0.73	T
Polyphen		0.026	B
Vest4		0.070
MutPred		0.14		Loss of glycosylation at P335 (P = 0.0716)
MVP		0.76
MPC		0.76
ClinPred		0.069	T
GERP RS		2.2
Varity_R		0.029
gMVP		0.33

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs169068; hg19: chr16-1129872;